We've been very aggressive in the financial benefit in implementing generic substitution and paying for generic, first, as an option. To answer your question, technology may bring some of the solution you're looking for. It's not necessary to have a plan or an individual between the physician, the patient, and the pharmacist. Technology can do a lot.
I was mentioning earlier that 96% of our claims go through directly, and a lot of controls are built into the technology. We can think about pushing that. Whether it's a national or local plan, we can think about using more technology so that when the physician prescribes something, the criteria are already made available to the physician up front and he or she can submit the reason why it is preferable to go to the second-line therapy right away, or whatever kind of information is needed.
We can simplify the life of the physician, the patient, the pharmacist, and the plan administrator as well. There is potential there and I think we are making some progress.